Are you or your child interested in participating in a research study?
If so, click on any of the links below to read more about the studies that are currently seeking participants. If you are interested in any of the studies, click on the listed email address which will allow you to e-mail your contact information to the research team. If no email address is listed, please call the listed telephone number.
Studies That Are Currently Recruiting
ADHD and Disruptive Behavior Disorders Alcoholism and Addictions Alzheimer's Disease, Dementia, and Cognitive Disorders Anxiety Disorders Autism Spectrum Disorders Bipolar Disorder Depression and Mood Disorders Fragile X Syndrome Schizophrenia
ADHD and Disruptive Behavior Disorders
RESEARCH STUDY FOR CHILDREN AND ADOLESCENTS WITH ADHD AND DYSLEXIA
Investigators at IU School of Medicine Department of Psychiatry are conducting a research study to test an investigational medication for children and adolescents (age 10-16) with ADHD and/or Dyslexia. Most eligible participants will have both conditions, but a smaller number of participants are needed with just one of the two conditions. Evaluations will be conducted during the screening process. There are up to 11 visits with participation lasting up to 10 months. Participants will receive study procedures and medication or placebo at no charge. Compensation is $25 per visit to offset travel expenses. To learn more information about this study and its requirements, call Riley Child and Adolescent Psychiatry Clinic at 317-278-3472 or email kidpsych@iupui.edu
For more information about this study, click here or click here.
RESEARCH STUDY FOR ADULTS WITH ADHD AND THEIR FAMILIES
Investigators at IU School of Medicine Department of Psychiatry are conducting a research study to test an investigational medication for adults with ADHD and to learn about the impact of adult ADHD on families. Must be living with a person of the opposite sex for at least 3 months and have a child 6-17 years of age living in the home. There are up to 13 visits with participation lasting up to 8 months. Participants will receive study procedures and medication or placebo at no charge. Participants are also compensated $20/visit. To learn more information about this study and its requirements, call Riley Child and Adolescent Psychiatry Clinic at 317-278-7333 or email kidpsych@iupui.edu.
For more information about this study, click here.
Alcohol and Addictions
PAID ALCOHOL STUDY - EARN $150
Do you regularly drink 5 or more drinks at least 4 times per week and have not received treatment for your drinking? The study involves, taking study medication for about 2 weeks, and 4 visits, 2 of which will take about 6 hours of your time. Call (317)278-1124 for info.
Anxiety Disorders
PANIC DISORDER TREATMENT STUDY
Racing heart? Shortness of breath? Losing control?
Do you have moments of sheer panic that come on out of the blue? Do you feel dizzy, break into a cold sweat and fear you are dying? These are all common signs of panic attacks.
The Indiana University Anxiety Disorders Clinic is looking for men and women over the age of 18 to participate in a clinical treatment study. If youare receiving the usual treatment for panic attacks but are not responding, please call 317-278-0038 extension 1 for more information.
Qualified participants will receive study-related medical care at no cost.
For more information about this study, click here.
OBSESSIVE-COMPULSIVE DISORDER (OCD) STUDY
Have you been diagnosed with a problem called Obsessive-Compulsive Disorder (OCD) and not responded to past medication or counseling treatment? If so, you may be eligible for a study examining if adding a medication called Paliperidone helps reduce your OCD symptoms. The Department of Psychiatry at IU School of Medicine is conducting this study.
To be eligible, you must be at least 18 years old and have problematic OCD symptoms despite having tried at least two OCD medications. If you participate in this study, you will be randomly assigned, that is by chance as in the “flip of a coin,” to receive either the study medication (Paliperidone) or a sugar pill in addition to the medication you are currently taking. There will also be eight psychiatric evaluations that take place. Study medication and the evaluations will be provided at no charge. Risks associated with the study will be disclosed prior to study participation.
For more information call (317) 278-0038, extension 1
Autism Spectrum Disorders
A PILOT STUDY OF ORAL N-ACETYLCYSTEINE
IN CHILDREN WITH AUTISM SPECTRUM DISORDERS
The Christian Sarkine Autism Treatment Center at Riley Hospital for Children is conducting a research study for 4 – 12 year old children who have an Autism Spectrum Disorder (ASD). Autism Spectrum Disorders include Autism, Asperger’s Disorder, and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS). If your 4 – 12 year old has an ASD, he or she may qualify for a research study involving study medication and clinic visits with a child psychiatrist and qualified research staff at no charge. The purpose of this study is to find out if the study medication will help to improve some of the behaviors associated with autism spectrum disorders. Participation requirements and risks involved in this study will be disclosed prior to study enrollment. If you are interested in participating or would like more information, please contact us at (317) 274-1218 or kidpsych@iupui.edu.
For more information about this study, click here.
NOVEL PHARMACOLOGICAL STRATEGIES IN AUTISM
The Christian Sarkine Autism Treatment Center at Riley Hospital for Children is conducting a Research Study for children and adolescents aged 5 – 17 years old who have Autism. If your 5 - 17 year old has Autism, he or she may qualify for a research study involving study medication and clinic visits with a child psychiatrist and qualified research staff at no charge. The purpose of this study is to find out if the medication, aripiprazole, is helpful for the treatment of irritability, aggression and/or self injurious behavior as well as to determine if adding the medication, D-cycloserine, improves social behavior in children and adolescents with autism.
In addition to free medication, some subjects may be able to participate in functional magnetic resonance imaging (fMRI) research designed to study brain activity.
Participation requirements and risks involved in this study will be disclosed prior to study enrollment. If you are interested in participating or would like more information, please call (317) 278-6253.
For more information about this study, click here.
TARGETED PHARMACOLOGICAL INTERVENTIONS FOR AUTISM: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ATOMOXETINE IN CHILDREN AND ADOLESCENTS WITH AUTISM
The Christian Sarkine Autism Treatment Center at Riley Hospital for Children is conducting a research study for children and adolescents ages 6 - 15 who have autism and who also have symptoms such as: overactivity, impulsivity, and/or inattention. The study involves a non-stimulant medication and clinic visits at no charge. If you would like to find out more about this research study at Riley Hospital for Children, please contact us at (317) 274-1218 or at kidpsych@iupui.edu.
For more information about this study, click here.
A PROSPECTIVE, OPEN-LABEL STUDY OF PALIPERIDONE ER IN ADOLESCENTS AND YOUNG ADULTS WITH AUTISM
The Christian Sarkine Autism Treatment Center at Riley Hospital for Children is conducting a Research Study for children and adolescents aged 12-21 years old who have Autism. If your 12-21 year old has Autism, he or she may qualify for a research study involving study medication and clinic visits with a child psychiatrist and qualified research staff at no charge. The purpose of this study is to find out if the medication paliperidone ER, is helpful for the treatment of irritability, aggression and/or self injurious behavior improves in adolescents and young adults with autism. Participation requirements and risks involved in this study will be disclosed prior to study enrollment. If you are interested in participating or would like more information, please call (317) 278-6253.
For more information about this study, click here.
Bipolar Disorder
A STUDY TO DETERMINE THE GENETIC AND ENVIRONMENTAL FACTORS ASSOCIATED WTH BIPOLAR DISORDER (FLYER)
John Nurnberger, Jr., M.D., Ph.D., at Indiana University School of Medicine and a collaborative team of psychiatric geneticists are conducting a four-year study, sponsored by the National Institute of Mental Health. The study is an attempt to identify genes and environmental factors that may be responsible for Bipolar Disorder. This information will hopefully lead to the development of new treatments for this disorder. For more information, please call us toll free at 1-888-750-2201, visit our website, www.iupui.edu/~bipolar or email at bipolar@iupui.edu
PERSONS WITH BIPOLAR DISORDER OR MOOD SWINGS ON LAMICTAL
Do you have Bipolar Disorder or Mood Swings?
Perhaps you can help us! The Indiana University Medical Center Mood Disorders Clinic is searching for adult mean and women who have bipolar disorder or mood swings and are currently on the medication Lamictal (lamotrigine) to participate in a clinical trial of a new investigational medication. Qualified participants will receive medical and pyschiatric exams and study medication at no cost. Risks associated with the study will be disclosed prior to study initiation.
For more information, call (317)278-3311. Please leave your name and a phone number at which you can easily be reached.
For more information about this study, click here.
PERSON WITH BIPOLAR DISORDER OR MOOD SWINGS
Do you have Bipolar disorder or mood swings?
Perhaps you can help us! The Indiana University Medical Center Mood Disorders Clinic is searching for people between the ages of 21-60 with bipolar disorder or mood swings to participate in a clinical trial. Qualified participants will receive medical and psychiatric exams at no cost. The study has 9 visits over about 9 weeks and consists of treatment with lithium in addition to brain scans(MRI). Risks associated with the study will be disclosed prior to study initiation.
For more information, call (317)278-3311. Please leave your name and a phone number at which you can easily be reached.
For more information about this study, click here.
Depression and Mood Disorders
DEPRESSION STUDY
Are you feeling low? Have you lost interest in the people and things that used to bring you joy? Do you lack the drive and energy to do the things you would like to do? Are you tired of feeling depressed?
If you answered YES to any of the questions above, you may be eligible to take part in a study for depression being conducted by the Indiana University School of Medicine Adult Psychiatry Clinic. We are looking for individuals between ages of 18 and 65 who are either suffering from depression and are not currently on any medications for depression.
This study has 9 visits over about 12 weeks and involves treatment with an FDA approved medication (duloxetine, also known as Cymbalta) and brain scans(MRI). All study procedures and study medication are provided to subjects free of charge. Compensation is up to $150.
Participation requirements and risks involved in this study will be disclosed prior to study enrollment.
If you are interested, please call (317)278-3311.
For more information about this study, click here.
Fragile X Syndrome
FRAGILE X SYNDROME RESEARCH STUDY
The Section of Child & Adolescent Psychiatry at Indiana University School of Medicine is conducting a study designed to study the effects of aripiprazole in individuals with Fragile X syndrome. Participants must be children between the ages of 6 and 35 with Fragile X syndrome as well as behavioral difficulties such as irritability, tantrums, aggression and self-injurious behavior. Participants must have no major medical illness and not have had a previous adequate trial of aripiprazole. Participants will receive study medication at no charge. For additional information about study requirements and study procedures, please call Marianna at (317) 278- 6253.
For more information about this study, click here.
THE NEUROBEHAVIORAL PHENOTYPE OF FRAGILE X SYNDROME
The Child & Adolescent Psychiatry Fragile X Syndrome Clinic at Riley Hospital for Children is conducting a Research Study for individuals age 7 & older with Fragile X Syndrome. Your 7 year or older child with Fragile X Syndrome may qualify for this study involving psychological testing & structured surveys designed to describe behaviors & mental illnesses common to Fragile X Syndrome. Participation requirements & risks involved in this study will be disclosed prior to study enrollment. If you are interested in participating or would like more information, please contact Marianna at (317) 278-6253.
For more information about this study, click here.
Schizophrenia
SCHIZOPHRENIA FAMILY STUDY
Drs. Brian O’Donnell Ph.D. and Anantha Shekhar M.D., Ph.D. from the Neuroscience Clinical Research Center at Indiana University School of Medicine are conducting a Schizophrenia Family Study.
There is evidence that schizophrenia may be influenced by genetic or medical factors in a family, and this project is seeking to identify such shared factors. We are gathering information from both patients and their relatives (parents, children or siblings) on tests of vision, learning, memory, attention and by collecting brainwave activity, to investigate the relationship between genetic relatedness and the symptoms of schizophrenia.
Our study is run from LaRue Carter Hospital in Indianapolis, and you will receive payment for participation. Transportation can be provided if needed.
If you or someone you know either has a diagnosis of schizophrenia or is related to someone who is, and would like to participate in our research project, please contact Dr. Brenner at (317) 941-4502 or via email at cobrenne@indiana.edu.